Clinical Trials
5 trialsNCT01673581 2026-05-15
Shared Decision Making in Low Risk Prostate Cancer
Massachusetts General Hospital
Withdrawn
NCT04565496 2026-05-15
PEM-PRO
IRCCS San Raffaele
Phase 2 Withdrawn
NCT07237399 2026-05-13
TA-P-OLIM
University Hospital, Ghent
Withdrawn
NCT06765902 2026-05-05
Immunotherapy Before and After Surgery
ImmunityBio, Inc.
Phase 2 Withdrawn
NCT06765954 2026-05-05
Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.
ImmunityBio, Inc.
Phase 2 Withdrawn